Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2011-01-04
2011-01-04
Fetterolf, Brandon J (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C424S465000
Reexamination Certificate
active
07863331
ABSTRACT:
Pharmaceutical compositions comprising micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant, wherein said compositions contain an amount of fenofibrate greater than or equal to 60% by weight and methods of producing fenofibrate compositions.
REFERENCES:
patent: 3914286 (1975-10-01), Mieville
patent: 4058552 (1977-11-01), Mieville
patent: 4344934 (1982-08-01), Martin et al.
patent: 4412986 (1983-11-01), Kawata et al.
patent: 4717569 (1988-01-01), Harrison et al.
patent: 4752470 (1988-06-01), Mehta
patent: 4800079 (1989-01-01), Boyer et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5545628 (1996-08-01), Deboeck et al.
patent: 5776495 (1998-07-01), Duclos et al.
patent: 5840330 (1998-11-01), Stemmle et al.
patent: 6074670 (2000-06-01), Stamm et al.
patent: 4895726 (2001-08-01), Curtet et al.
patent: 6277405 (2001-08-01), Stamm et al.
patent: 6368620 (2002-04-01), Liu et al.
patent: 6667064 (2003-12-01), Surette
patent: 2006/0083783 (2006-04-01), Doyle, Jr. et al.
patent: 2007/0071812 (2007-03-01), Criere et al.
patent: 2008/0248101 (2008-10-01), Criere et al.
patent: 012523 (1980-06-01), None
patent: 0164959 (1985-12-01), None
patent: 0 330 532 (1989-08-01), None
patent: 0 514 967 (1992-11-01), None
patent: 0 519 144 (1992-12-01), None
patent: 793958 (1997-09-01), None
patent: 219 341 (1997-03-01), None
patent: WO82/01649 (1982-05-01), None
patent: WO96/01621 (1996-02-01), None
patent: 98/00116 (1998-01-01), None
patent: 98/31361 (1998-07-01), None
patent: WO98/31360 (1998-07-01), None
patent: WO 01/03693 (2001-01-01), None
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Oct. 1997 pp. 1-8.
cancerweb.ncl.ac.uk/cgi-bin/omd?inert 1997, 1 page.
www.pslgroup.com/dg, 2pages, 1998.
The Merck Index—An encyclopedia of chemicals, drugs and biologicals. Twelfth edition. 1996, p. 3260.
The Merck Index—An encyclopedia of chemicals, drugs and biologicals. Thirteenth edition. 2001, p. 3238.
A. Munoz et al., “Micronised Fenofibrate”,Atherosclerosis110 (Suppl.) (1994) S45-S48, Elsevier Science, Ireland.
D.F. Temeljotov et al., “Solubilization and Dissolution Enhancement for Sparingly Soluble Fenofibrate”,Acta. Pharm. 46 (1996) 131-136.
R. Bianchini et al., “Influence of Drug Loading on Coated Beads Release Using Air Suspension Technique”,Boll. Chim. Farmaceutico, 128 Dec. 12, 1989, pp. 373-379.
Dr. Bernhard Luy, “Methods of Pellet Production”, Presented at Glatt Symposium, Strasbourg, Oct. 1992, pp. 1-12, with curriculum vitae.
A. Kuchiki et al., “Stable Solid Dispersion System Against Humidity”,Yakuzaigaku44(1) 31-37 (1984) pp. 1-13.
JP Guichard et al., “A New Formulation of Fenofibrate: Suprabioavailable Tablets”,Current Medical Research and Opinion16(2) (2000) pp. 134-138, Laboratoires Fournier, France.
El-Arini et al., “Dissolution Properties of Praziquantel-PVP Systems”.Pharmaceutical Acta Helvetiaev. 72, pp. 89-94 (1998).
International Search Report issued Oct. 26, 2000 in PCT/FR 00/01971.
Bobotas George
Chenevier Philippe
Criere Bruno
Oury Pascal
Rotenberg Keith S.
Buchanan & Ingersoll & Rooney PC
Ethypharm
Fetterolf Brandon J
Gembeh Shirley V
LandOfFree
Pharmaceutical composition containing fenofibrate and method... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing fenofibrate and method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing fenofibrate and method... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2742849